CED Digest: 239 Items — March 17, 2026

Alabama Medical Cannabis Sales Gear for Spring 2026 Launch

Alabama’s medical cannabis program expects to begin patient sales in spring 2026, requiring clinicians to prepare for prescribing protocols and patient care delivery in a newly regulated market.

Cannabis compounds CBD and CBG may help reverse fatty liver disease, study finds

Cannabis compounds CBD and CBG show potential therapeutic effects against hepatic steatosis, offering clinicians evidence-based cannabinoid applications for metabolic liver disease management.

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …

The article examines regulatory enforcement actions against hemp-derived cannabis products, which clinicians must understand to advise patients on legal product safety and efficacy claims.

Cannabis Compounds CBD and CBG Show Promise in Reducing Liver Fat and Improving …

Cannabis compounds CBD and CBG demonstrate potential therapeutic effects on hepatic steatosis and metabolic function, offering clinicians evidence-based options for patients with fatty liver disease.

New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …

New Top Cannabis Regulator Sets Priorities In First Board Meeting

A newly appointed cannabis regulator outlined priorities at their initial board meeting, establishing policy direction that will shape regulatory compliance and clinical practice standards for healthcare providers.

Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead

Brazil’s evolving cannabis regulations, clinical applications, and implementation challenges are examined to guide healthcare providers navigating the country’s emerging legal medical cannabis framework.

2 Greater Cincinnati breweries file lawsuit over Ohio ban on THC beverages – WLWT

Two Cincinnati breweries are challenging Ohio’s prohibition on THC-infused beverages through litigation, establishing legal precedent for cannabis product regulation and market access in the state.

New Ohio law means THC-infused drinks won’t be available on many store shelves – WTVG

Ohio law restricts THC-infused beverage distribution in retail settings, requiring clinicians to understand regulatory limitations affecting patient access to alternative cannabis delivery methods.

Lawmakers strike down bill capping THC levels in Oregon’s cannabis edibles – Yahoo

Oregon lawmakers rejected legislation that would have limited THC potency in edible cannabis products, leaving current high-potency products available to patients and consumers.

Attempt to limit potency of THC in marijuana edibles fails at Oregon Legislature

Oregon legislators failed to pass potency limits on THC in marijuana edibles, affecting dosing standardization and clinical considerations for patient safety and consistent therapeutic outcomes.

Cannabis Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health

Cannabis compounds CBD and CBG reduce hepatic steatosis and improve metabolic markers, offering potential therapeutic applications for non-alcoholic fatty liver disease management in clinical practice.

Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and … – PubMed

This article examines formulation and fabrication methods for delivering cannabinoids through oral mucosal routes, which is relevant to clinicians seeking alternative administration methods to optimize cannabinoid bioavailability and patient outcomes.

Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML

CBD-dominant cannabis products demonstrate measurable anxiolytic effects, providing clinicians with evidence-based cannabinoid formulations for anxiety management in patient care.

Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML

A clinical trial demonstrates cannabis extracts’ efficacy in reducing myofascial pain, providing evidence-based data clinicians can reference when treating patients with this condition.

As a Medical Cannabis Patient, I’m Watching This Supreme Court Case Closely

A medical cannabis patient discusses monitoring a Supreme Court case with direct implications for patient rights, access, or regulatory framework affecting clinical cannabis practice.

The Week in Weed: March 2026 | Seyfarth Shaw LLP – JDSupra

**This legal briefing covers cannabis regulatory and legislative developments relevant to clinicians managing patient care within evolving compliance frameworks.**

Marijuana gummies sold in Ohio recalled. Why, where they were sold – The Columbus Dispatch

Marijuana gummies sold in Ohio were recalled, likely due to safety or quality concerns relevant to clinicians counseling patients on product safety and regulatory compliance.

New Group Launches Ahead of Medicare CBD Pilots – Cannabis Wire

A new organization has formed to prepare for upcoming Medicare pilot programs testing CBD, which could expand clinical access and insurance coverage for cannabis-derived treatments.

Marijuana Status Based Prohibition Tag Archives – Powers Law Firm PA

This archive covers legal prohibition frameworks for marijuana, providing clinicians with essential information about regulatory status that affects prescribing authority, patient access, and compliance requirements across jurisdictions.

Louisiana lawmaker files bill to legalize recreational marijuana through licensed dispensaries

A Louisiana legislator proposed legalizing recreational marijuana sales through regulated dispensaries, which would expand patient access and create clinical implications for healthcare providers managing cannabis use.

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries

A Georgia mother’s homemade medical cannabis formulation has been commercialized and is now available at licensed dispensaries, demonstrating patient-developed preparation methods entering regulated markets.

Ohio THC drink ban draws lawsuit from Cincinnati breweries

Ohio’s THC beverage restriction faces legal challenge from breweries, affecting regulatory landscape for cannabis-infused drink products and clinical considerations around alternative consumption methods.

Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease

Israeli researchers identified cannabis compounds as potential therapeutic agents for fatty liver disease, offering cannabis clinicians evidence-based treatment options for a prevalent hepatic condition.

Virginia adult-use sales bills pass both chambers, head to conference committee! – Blog

Virginia’s adult-use cannabis sales legislation passed both chambers and requires reconciliation, establishing a regulatory framework that clinicians must monitor for implications on medical cannabis programs and patient access.

Study highlights pros, cons of medical marijuana as its future in Tennessee remains unknown

This article examines clinical evidence for medical marijuana’s therapeutic benefits and limitations, addressing Tennessee’s uncertain regulatory pathway for physician implementation.

2026 Utah legislature on cannabis, psychedelics and kratom – Fox 13

The 2026 Utah legislature addresses cannabis, psychedelics, and kratom policy, directly affecting clinical practitioners’ legal framework for patient care and treatment options in the state.

Oregon Bill To Ban Marijuana Edibles With More Than 10 Milligrams Of THC Fails

Oregon’s proposed legislation to limit THC content in marijuana edibles to 10mg per serving failed to pass, maintaining current regulations affecting dosing considerations for clinical cannabis recommendations.

Georgia bill could limit probable cause for smell of marijuana, cannabis, or hemp – YouTube

Georgia legislation would restrict law enforcement’s use of cannabis odor alone as grounds for searches, affecting legal distinctions between hemp and marijuana that clinicians must navigate.

Study reveals cannabis compounds reduce threat of fatty liver disease | Health

Cannabis compounds may reduce fatty liver disease risk, which matters to clinicians because it identifies a potential therapeutic application for cannabis in managing a common metabolic condition.

Prescription Cannabidiol CBD Oil Market to Hit US$ 190.9 Billion by 2032 at 23.48% CAGR

The prescription CBD oil market is projected to reach $190.9 billion by 2032, reflecting significant growth that indicates expanding clinical applications and potential increased accessibility of cannabinoid therapeutics.

TPS Cannabis News – StratCann

I’m unable to complete this task because no article content was provided—only a title and empty summary field. Please share the article text so I can write an accurate summary for cannabis clinicians.

InMed Pharmaceuticals Shifts Focus to Therapeutic Programs, Ends BayMedica’s Non …

InMed Pharmaceuticals discontinued a non-psychoactive cannabis product line through BayMedica, redirecting resources toward clinical therapeutic programs—relevant for clinicians tracking cannabinoid-based pharmaceutical development.

Cannabis Extracts Significantly Reduce Myofascial Pain | Trending – Labroots

**Summary:** This article examines research on cannabis extract efficacy for myofascial pain treatment, relevant to clinicians evaluating cannabinoid-based therapeutic options for musculoskeletal pain management.

Pediatricians warn about cannabis use disorder, kids’ easy access to the drug – YouTube

Pediatricians document cannabis use disorder in children and adolescents, highlighting concerning trends in youth accessibility that clinicians must address in prevention and treatment protocols.

West Virginia House Passes Bill To Allocate Medical Marijuana Revenue, With Some …

West Virginia enacted legislation directing medical marijuana tax revenues toward specific allocations, establishing fiscal frameworks that clinicians should monitor for program funding and regulatory resource impacts.

Study highlights positive, negatives of medical marijuana – WKRN News 2

This article reports on research examining both therapeutic benefits and risks of medical marijuana, providing clinicians with evidence-based information for patient treatment decisions.

The science behind roadside THC testing and diving into SGI’s zero-tolerance policy – Global News

This article examines roadside THC detection methods and Saskatchewan Government Insurance’s zero-tolerance impaired driving policy, relevant to clinicians assessing cannabis-related impairment and patient safety implications.

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries

A Georgia mother’s homemade medical cannabis formulation has entered commercial dispensary distribution, demonstrating patient-developed preparations gaining regulatory approval and clinical market access.

‘Pot for Potholes Act’ aims to legalize marijuana in Tennessee and distribute taxes to repair …

A Tennessee legislative proposal seeks to legalize marijuana and allocate tax revenue to infrastructure repair, potentially expanding patient access and creating regulatory frameworks relevant to clinical cannabis practice.

One of Colorado’s Largest Dispensary Chains Agrees to Buyout – Denver Westword

A major Colorado dispensary chain is being acquired, which may affect cannabis product availability, pricing, and regulatory compliance standards for clinicians’ patients in that market.

Cannabis legalization driving increases in marijuana use among US adults with historically … – MSN

Ohio Department of Commerce recalls certain marijuana gummies lacking THC symbol … – Facebook

Perceptions of the relative harmfulness of marijuana and alcohol among adults in Oregon.

This study examines how Oregon adults perceive marijuana versus alcohol health risks, providing clinicians data on patient beliefs that may influence treatment discussions and health counseling outcomes.

What’s Really Happening With Cannabis ETF MSOS? – The Dales Report

This article examines MSOS, a cannabis exchange-traded fund, relevant to clinicians tracking cannabis industry financial trends and market accessibility for investment or research purposes.

Study reveals cannabis compounds reduce threat of fatty liver disease – Daily Journal

Cannabis compounds show potential in reducing fatty liver disease risk, providing clinicians evidence-based information for patient counseling regarding hepatic health outcomes.

Scientists are raising new concerns about marijuana use in teens – KPBS

Adolescent cannabis use correlates with increased psychiatric risk including psychosis, depression, and anxiety, making developmental neurobiology critical for clinicians treating teen patients.

Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML

A clinical trial shows sublingual cannabis extracts reduce myofascial pain in temporomandibular disorder patients, expanding evidence for cannabinoids in pain conditions resistant to conventional treatments.

Can the placenta predict schizophrenia risk? Lessons from prenatal cannabis exposure

This research examines placental biomarkers as potential early indicators of schizophrenia risk following prenatal THC exposure, relevant to clinicians counseling pregnant patients on cannabis use risks.

Scientists are raising new concerns about marijuana use in teens – YouTube

This article discusses THC’s effects on adolescent brain development and links frequent teen cannabis use to disruptions, critical knowledge for clinicians treating young patients.

A huge study finds a link between cannabis use in teens and psychosis later – NPR

A large study documents the association between teenage cannabis use and later psychosis risk, informing clinical assessment and patient counseling on developmental vulnerability.

Teen Cannabis Use Tied to Increase in Serious Mental Illness – Medscape

Adolescent cannabis use during critical brain development periods increases risk for serious psychiatric conditions like psychosis and bipolar disorder, informing clinical assessment and patient counseling.

Brain Researchers Finally Know Why Cannabis Use Increases Appetite – The Debrief

Recent neuroscience research has identified the specific brain mechanisms by which cannabinoids stimulate appetite, providing clinicians with evidence-based understanding of the “munchies” effect for patient education and therapeutic applications.

Teen Marijuana Use Doubles Chances of Future Psychotic Disorders, Study Finds

Early adolescent cannabis use is associated with increased adult psychotic disorder risk, making developmental timing critical for clinical assessment and patient counseling.

The association between cannabis use and brain reward anticipation: a 12-month … – Nature

This research examines how cannabis use affects brain reward processing, relevant to clinicians evaluating cannabis-related effects on motivation and pleasure responses in patients.

THC levels in blood and urine are “unreliable” indicators of driving impairment – leafie

THC blood/urine levels don’t reliably indicate driving impairment due to the drug’s tissue distribution, requiring clinicians to assess impairment through behavioral observation rather than biomarker thresholds.

Study Links Prenatal Cannabis Exposure To Schizophrenia – New Telegraph

Prenatal cannabis exposure may create placental biological changes associated with increased offspring schizophrenia risk, requiring clinicians to counsel pregnant patients on potential neurodevelopmental concerns.

The Endocannabinoid System’s Contribution to Placebo Analgesia – bioRxiv

This research identifies the endocannabinoid system’s role in placebo analgesia, demonstrating that expectation-driven pain relief and cannabis-based treatments may share common neurobiological mechanisms.

Modulating the endocannabinoid system in alcohol use disorder: A translational systematic …

This article examines how cannabinoid receptors and endogenous ligands modulate brain systems dysregulated in alcohol use disorder, potentially informing therapeutic targeting strategies for co-occurring conditions.

Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – The Hill

Cannabis hyperemesis syndrome causes cyclic severe nausea and vomiting in chronic heavy users, requiring clinicians to recognize and differentiate it from other gastrointestinal conditions for appropriate patient management.

Association of Cannabis Use Disorder Versus Other Substance Use Disorders … – Psychiatry Online

This research compares cannabis use disorder’s psychiatric impact to other substance use disorders, helping clinicians assess relative clinical burden amid changing legal environments.

Study Shows Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia …

This research challenges the assumption that lifetime cannabis use causes cognitive decline or dementia, providing clinicians evidence-based information for patient counseling and risk assessment.

Study Finds No Link Between Lifetime Cannabis Use and Cognitive Decline in Older Adults

This study reports no association between lifetime cannabis use and cognitive decline in older adults, relevant to clinicians assessing safety profiles for elderly patients.

Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease

Israeli researchers identified cannabinoid compounds effective against non-alcoholic fatty liver disease, potentially offering the first pharmaceutical treatment for a condition affecting hundreds of millions worldwide.

The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators

This article examines barriers preventing international cannabis companies from entering the U.S. market, relevant to clinicians navigating evolving regulatory landscapes affecting patient access and treatment options.

North Shore Dispensary opens in Duluth’s Lincoln Park – WDIO.com

North Shore Dispensary opened in Duluth’s Lincoln Park neighborhood, expanding local cannabis retail access for patients and consumers in the region.

Study reveals cannabis compounds reduce threat of fatty liver disease | Health – News-Topic

Research indicates cannabinoids may reduce non-alcoholic fatty liver disease risk through anti-inflammatory and metabolic mechanisms, potentially expanding therapeutic applications for patients with hepatic conditions.

Observational study on medical marijuana use seeks Arizona participants – KJZZ

This article discusses an observational study recruiting Arizona participants to generate real-world evidence on medical cannabis use, which complements controlled trials by capturing diverse patient conditions and consumption patterns.

Cannabis compounds show promise in fighting fatty liver disease, scientists say – AZERTAC

A huge study finds a link between cannabis use in teens and psychosis later – KUOW

Adolescent cannabis use is associated with increased psychosis risk in adulthood, which is clinically relevant for assessing developmental vulnerability and informing patient counseling about long-term mental health outcomes.

Prescribed cannabis and driving behaviours among two samples of people who regularly … – UNSW

Medical cannabis patients’ driving safety requires understanding how THC dose and timing affect psychomotor function and reaction time, since impairment levels don’t correlate simply with measured THC concentrations.

Cannabis research: India to start human trials for medicinal marijuana – NewsBytes

India is initiating human clinical trials for medicinal cannabis, providing controlled safety and efficacy data that will inform evidence-based clinical practice guidelines in a traditionally restrictive regulatory environment.

Cannabis Munchies Driven by Brain Reward Signals | Technology Networks

Cannabis activates brain reward pathways that drive increased eating; understanding this mechanism helps clinicians explain and potentially manage cannabis-related appetite changes in patients.

The association between cannabis use and brain reward anticipation: a 12-month … – Nature

This study examines how cannabis use affects reward processing in the developing brain over 12 months, which is relevant for clinicians assessing neurodevelopmental risks in adolescent cannabis users.

Screaming, vomiting, and daily weed: The rise of ‘scromiting’ among chronic cannabis users

Cannabinoid hyperemesis syndrome causes cyclical nausea, vomiting, and abdominal pain in chronic cannabis users; clinicians must recognize this paradoxical condition to provide accurate diagnosis and appropriate patient management.

Study finds no links between cannabis use and cognitive decline or dementia in older people

This research challenges the assumption that cannabis use causes cognitive decline or dementia in older adults, informing clinical risk-benefit discussions with this patient population.

Cannabis Use and Brain Aging: What a Major Study Reveals – Born2Invest

This article reports research findings on whether cannabis use correlates with changes in brain aging metrics, relevant for clinicians assessing long-term neurological effects in patients.

Cannabis use not linked to cognitive decline or dementia in older adults, study finds – leafie

Research indicates cannabis use in older adults does not accelerate cognitive decline or increase dementia risk, informing clinical safety assessments for this population.

Study reveals cannabis compounds reduce threat of fatty liver disease | Health – WFMZ.com

Preclinical research indicates CBD and THC may reduce liver fat accumulation and inflammation in metabolic-associated steatotic liver disease, potentially offering therapeutic applications for hepatic health.

Placental Changes From Prenatal Cannabis Exposure Could Flag Higher Schizophrenia …

Prenatal cannabis exposure causes placental epigenetic changes linked to neurodevelopmental disorders like schizophrenia, providing clinicians a potential biomarker for identifying at-risk pregnancies.

Teens Who Use Cannabis Face Higher Risk Of Mental Disorders, Study Finds – Forbes

Adolescent cannabis use correlates with increased psychiatric disorder risk, emphasizing clinicians’ need to assess developmental stage and implement preventive interventions during patient care.

A huge study finds a link between cannabis use in teens and psychosis later – WBAA

A large-scale study demonstrates adolescent cannabis use increases psychosis and depression risk in adulthood, supporting clinical guidance to discourage teen use during critical brain development.

Researcher: Remediated cannabis may still have harmful mold – MJBizDaily

Cannabis remediation may not eliminate all harmful molds, posing risks to immunocompromised patients despite passing state testing requirements.

So, What Does an Adult at Low Risk of Cannabis Dependence Look Like?

This article identifies clinical risk factors for cannabis dependence in adults, helping physicians determine which patients can safely use cannabis therapeutically with minimal dependence risk.

Cannabis hyperemesis syndrome cases surge in Virginia ERs – YouTube

Cannabis hyperemesis syndrome presentations are increasing in Virginia emergency departments, making recognition and management of this cyclical vomiting condition clinically important for healthcare providers.

Study Finds Veterans With SUD Used Cannabis to Alleviate Pain, Anxiety, and Improve Poor …

Veterans with substance use disorders used cannabis to self-manage pain, anxiety, and sleep issues during addiction treatment, informing clinical approaches to co-occurring cannabis and SUD treatment.

ARTELO BIOSCIENCES, INC. SEC 10-K Report – TradingView

Artelo Biosciences’ SEC filing documents targeted cannabinoid therapeutic development for specific medical conditions, reflecting pharmaceutical industry movement toward evidence-based cannabinoid medicines beyond whole-plant products.

Bill to protect Nebraska physicians recommending medical cannabis advances to floor

Nebraska legislation protects physicians from licensing board penalties when recommending medical cannabis, removing a major barrier that previously discouraged qualified doctors from offering this treatment option.

Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical …

This research examines how cannabis interacts with alcohol, caffeine, exercise, and sleep to affect anxiety in medical patients, helping clinicians make informed treatment decisions.

Nebraska bill to protect healthcare practitioners who recommend medical cannabis sails out of com…

Nebraska legislation protects healthcare practitioners from legal liability when recommending medical cannabis, addressing regulatory alignment between voter-approved medical programs and physician safeguards.

Major study finds strong link between cannabis, anxiety and depression – Medical Xpress

This article reports observational evidence linking cannabis use with anxiety and depression, highlighting the clinical challenge of distinguishing whether cannabis causes these conditions or users self-medicate with cannabis.

Research: Munchies May Aid Those Lacking Appetite – Pullman Today

Cannabis activates CB1 receptors in hunger-regulating brain regions, stimulating appetite—a mechanism clinicians can leverage therapeutically for patients with appetite loss conditions.

President Biden Signs Historic Cannabis Research Bill – Ganjapreneur

President Biden signed a federal cannabis research bill that removes bureaucratic barriers to cannabinoid research, enabling clinicians to conduct rigorous clinical investigations previously restricted by federal regulations.

Marijuana Use & Dangers for Adolescents & Young Adults

This article addresses cannabis’s neurological impacts on developing brains during adolescence and early adulthood, essential knowledge for clinicians assessing risk and treating cannabis use disorder in younger populations.

Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – KGET.com

Cannabis hyperemesis syndrome is a paradoxical condition causing severe nausea and vomiting in chronic heavy users; clinicians must recognize this counterintuitive adverse effect for proper diagnosis and treatment.

Study Published in Pediatrics Finds Infrequent Cannabis Use Can Impact Adolescent …

This study demonstrates that adolescent cannabis use at low frequencies (monthly or less) correlates with academic decline, expanding clinical evidence beyond heavy-use harm paradigms.

Pipeline Progress Drives Investor Focus at Agentix – Ad-hoc-news.de

Pharmaceutical companies are developing targeted cannabinoid receptor drugs instead of whole-plant cannabis, representing a shift toward precision medicine in endocannabinoid system treatment.

Study: Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia Risk in … – NORML

This study examines the relationship between lifetime cannabis use and cognitive decline or dementia risk in older adults, informing clinical counseling about long-term neurological safety.

Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML

CBD-dominant cannabis products show clinical potential for anxiety relief, offering clinicians an evidence-based alternative treatment option with favorable symptom outcomes in patients.

Toronto police shutdown multiple unlicensed cannabis dispensaries – CP24

Toronto police closed unlicensed cannabis dispensaries, affecting access to unregulated products and highlighting enforcement of legal sales channels clinicians should counsel patients about.

Using cannabis to cut back on alcohol? Your working memory might dictate if it works

Cannabis use may affect alcohol reduction outcomes differently based on individual working memory capacity, a finding relevant to clinicians counseling patients on substitution strategies.

Kentucky bill would change how alcohol, cannabis beverages are taxed – WKYT

Kentucky legislation proposes altering tax structures for alcohol and cannabis beverages, potentially affecting product pricing, market competitiveness, and patient access to cannabis-based medicines.

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries – WALB

A Georgia mother’s homemade medical cannabis formulation has entered commercial distribution through licensed dispensaries, demonstrating patient-developed products gaining regulatory approval and market access.

Teens Didn’t Just Discover Weed. So Why Is The Wall St. Journal Acting Like They Did?

The article critiques media coverage of teen cannabis use that presents established trends as novel discoveries, relevant for clinicians evaluating actual epidemiological patterns versus sensationalized reporting.

Exploring the Growing Trust in Cannabidiol Oil – The Assam Tribune

This article examines increasing confidence in cannabidiol (CBD) oil as a therapeutic option, relevant to clinicians evaluating evidence-based cannabinoid treatments for patient care.

Cannabis payouts drop for most Oakland County communities

Oakland County cannabis tax revenues declined for most communities, affecting funding for healthcare services and clinical operations that depend on cannabis licensing fees.

New Cannabis Dispensary Opens On Route 22 In Somerville | Bridgewater, NJ Patch

A new cannabis dispensary opened on Route 22 in Somerville, New Jersey, expanding retail access in the region for patients and consumers in that area.

Cannabis use by teenagers doubles their risk of developing psychotic and bipolar disorders

Cannabis use in adolescents is associated with doubled risk of psychotic and bipolar disorders, representing a critical clinical consideration for patient screening, counseling, and treatment planning.

Pediatricians warn about cannabis use disorder, kids’ easy access to the drug

Pediatricians highlight cannabis use disorder in children and barriers to prevention, relevant to clinicians managing cannabis-related conditions across age groups.

Teen Cannabis Use May Double Your Risk of Psychosis and Bipolar

This article examines the established link between adolescent cannabis use and increased psychosis and bipolar disorder risk, critical information for clinicians assessing psychiatric vulnerability in younger patients.

Can You Drive the Next Morning After Weed? Study Finds No Significant Impairment 12–15 …

This article examines next-day driving safety after cannabis use, addressing a critical clinical question about impairment timing and patient counseling regarding cannabinoid pharmacokinetics and individual variability.

Medicare may soon cover certain cannabis medications for seniors – MSU Denver RED

Medicare coverage of cannabis-based medications would expand treatment options for seniors with chronic pain, sleep disorders, and neuropathic conditions, affecting prescribing practices and patient access.

Placenta May Hide Early Warning Signs of Schizophrenia Risk – ScienceAlert

Prenatal THC exposure may create detectable placental biomarkers associated with schizophrenia risk, highlighting the importance of cannabinoid counseling for pregnant patients.

Bridging the Gap: Medical Cannabis, Regulators, and the Reality of Clinical Accountability

Medical cannabis prescribers operate under the same regulatory and professional standards as other physicians, requiring equivalent documentation, clinical reasoning, and patient safety practices.

Cannabis use, anxiety and depression are all on the rise in Canada: study – CTV News

This article reports a correlation between rising cannabis use and anxiety/depression rates in Canada, highlighting clinical concerns about cannabis’s potential mental health effects that clinicians should monitor.

A Prescription Digital Therapeutic Framework for Enhancing Medical Cannabis Care

This article examines how digital therapeutic tools can standardize medical cannabis treatment through personalized dosing, outcome tracking, and structured clinical protocols to improve patient care accountability.

Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial

Ananda Pharma is launching an NHS-supported clinical trial testing CBD’s efficacy for endometriosis-related pelvic pain, addressing a significant treatment gap for undertreated patients.

Washington Senators Approve Bill To Let Terminally Ill Patients Use Medical Cannabis In Hospitals

This bill allows terminally ill patients to use state-approved medical cannabis in hospitals, bridging the gap between legal medical cannabis access and institutional healthcare policies.

Natural Neuroprotection: Exploring the Potential of Non-Psychoactive Cannabinoids

This article examines how non-psychoactive cannabinoids (CBD, CBG, CBDV) may protect neurons by modulating inflammation and oxidative stress, relevant for clinicians treating neurodegenerative conditions.

America Doesn’t Have A ‘Marijuana Problem,’ As NYT Claims—It Has a Cannabis Education …

This article argues that cannabis education gaps in medical training and research, rather than the plant itself, drive mainstream “marijuana problem” framing—relevant for clinicians seeking evidence-based practice standards.

Are My THC Gummies Going Away? – Science Friday

The article examines the regulatory uncertainty surrounding hemp-derived THC gummies and potential federal policy changes that could affect patient access to these products.

House panel approves proposed medical cannabis law – POLITIKO

The Philippines is advancing medical cannabis legislation to establish regulated research infrastructure and patient access pathways, expanding clinical practice opportunities in a previously restricted market.

What effects does THC have on youth who dabble? – YouTube

This article examines THC’s effects on developing adolescent brains during critical neurodevelopmental periods, relevant for clinicians assessing cannabis-related risks in young patients.

Tennessee sisters fear new hemp law as CBD oils become harder to access – YouTube

Tennessee’s hemp law restrictions are limiting patient access to full-spectrum CBD products that some dystonia patients rely on for symptom management.

“Mother of Cannabinoids”: The Rising Potential of CBG and CBG-A – Cannabis Health News

This article examines CBG and CBGA’s emerging therapeutic potential for anxiety, memory, and anti-cancer applications, providing clinicians with evidence-based information on understudied cannabinoid alternatives to THC and CBD.

Ghana launches medicinal cannabis programme under strict regulation

Ghana’s regulated medicinal cannabis programme enables West African clinical research and population-specific efficacy data, advancing evidence-based cannabis medicine practice in a previously restricted region.

Patient Protect launches to tackle discrimination against UK medical cannabis patients

This article covers discrimination faced by UK medical cannabis patients across housing, employment, and law enforcement, which clinicians should understand affects patient wellbeing and treatment outcomes.

Study Links Rising Cannabis Use to Poor Mental Health – U.S. News & World Report

This article examines how cannabis use affects mental health in older adults, informing clinicians about age-specific metabolic factors relevant to geriatric patient care.

Natural Approaches to Managing Chronic Inflammation – WorldHealth.net

This article examines how the endocannabinoid system regulates inflammation and immune function, and how plant-derived cannabinoids like CBD and THC interact with these pathways—relevant to treating inflammatory conditions.

Alabama medical cannabis program is now accepting patient registrations! – Blog

Alabama’s new medical cannabis program enables clinicians to recommend cannabis for qualifying conditions including chronic pain, PTSD, and anxiety, expanding treatment options in a previously restrictive state.

House panel revives medical cannabis bill – Daily Tribune

The Philippines is establishing a regulated medical cannabis framework through House committee approval, creating new clinical access and treatment opportunities in a previously prohibited market.

More Kentucky children dying to ‘preventable’ overdoses, new report shows

This report documents pediatric cannabinoid overdoses linked to unsafe storage, emphasizing clinicians’ role in counseling patients on childproof containment and safe household practices.

Legislation on medical cannabis: DOH bares conditions – Cebu Daily News

Medical cannabis regulation in the Philippines requires clinical and scientific evidence for legal access, directly affecting clinicians’ ability to prescribe and patients’ legal treatment options.

Sober shift could reshape spending, but doctor warns THC may be the new vice – Fox Baltimore

As alcohol use declines in the U.S., cannabis consumption rises, requiring clinicians to understand THC’s health effects and potential for substituting one psychoactive substance for another.

Secondhand marijuana smoke has fine particles that can cause asthma attacks and … – Instagram

Secondhand marijuana smoke contains particulate matter that triggers respiratory inflammation and asthma exacerbation, requiring clinicians to counsel patients on inhalation exposure risks.

Nebraska’s Medical Cannabis Commission holds hearing on emergency regulations – KETV

Nebraska’s medical cannabis commission established emergency regulations capping THC possession at 5 grams per 90 days, potentially limiting therapeutic efficacy for qualifying patients.

Nebraska Bill Seeks To Shield Doctors Recommending Medical Cannabis From Arrest

Nebraska legislation would protect physicians from arrest for recommending medical cannabis, enabling doctors to practice without criminal liability concerns.

The Week in Weed: February 27, 2026 – Lexology

Recent research documents measurable physiological and psychoactive responses from acute cannabis use, providing evidence-based data clinicians can reference when assessing patient effects and safety profiles.

First-of-its-kind long-term study at Virginia Tech shares how cannabis use can affect driving

This study examines how THC impairs specific driving skills differently than alcohol, with implications for clinicians assessing patient safety and driving ability.

Expert breaks down hidden dangers of doctors prescribing medical marijuana – UNILAD

This article discusses Cannabis Use Disorder prevalence rates and concerns about physician prescription practices, relevant to clinicians assessing patient risk and treatment outcomes.

Hemp article tells us why WI needs government regulations | Letter – Milwaukee Journal Sentinel

Hemp-derived cannabis products lack testing and labeling standards equivalent to regulated dispensary products, creating consumer safety risks that clinicians should understand when counseling patients.

Campaign Launched in Memory of Mum Who Helped Change UK Medical Cannabis Law

Medical cannabis shows proven efficacy for drug-resistant childhood epilepsy syndromes like Dravet and Lennox-Gastaut, making cannabidiol a clinically relevant treatment option for practitioners managing intractable seizure disorders.

New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …

A new cannabis medicine group aims to inform federal cannabinoid policy with scientific evidence and patient perspectives during ongoing rescheduling discussions.

Hey Sonar: Rethinking your relationship with weed – CSU Signal

I’m unable to provide an accurate summary because the article content wasn’t included—only the title and empty summary field are visible. Please share the article text or full summary for an accurate one-sentence description.

‘Green lab’ helps Oregon officers recognize marijuana-impaired driving | The Astorian

Oregon law enforcement uses a “green lab” training program to help officers detect marijuana impairment in drivers, addressing clinical needs for standardized impairment assessment protocols.

Medical marijuana as someone working in healthcare industry : r/florida – Reddit

This Reddit discussion covers healthcare workers’ perspectives on medical marijuana use and practice in Florida, relevant to clinicians navigating professional considerations and patient care protocols.

Medical and recreational marijuana bills introduced in Kansas Legislature – KAKE

Kansas Legislature is considering medical and recreational marijuana bills, which would create clinical frameworks for patient access in a state currently prohibiting all cannabis use.

Study highlights pros, cons of medical marijuana as its future in Tennessee remains unknown

This article examines Tennessee’s evolving political landscape toward medical marijuana legalization and the clinical evidence supporting its therapeutic applications for healthcare providers.

The House Committee on Dangerous Drugs, together with the Committee on Health … – Facebook

The Philippine House is developing medical cannabis legislation with regulatory frameworks and research provisions, directly impacting clinical practice standards and patient access for healthcare providers.

Health advocate underscores ‘real danger’ in medical cannabis legalization in PH

This article examines Philippine regulatory and healthcare capacity concerns regarding medical cannabis legalization, directly relevant to clinicians implementing safe prescribing protocols.

Extended moratorium on Oklahoma medical marijuana business licenses approved by House

Oklahoma’s House approved an extended moratorium on medical marijuana licenses to address market oversaturation, regulatory challenges, and quality control issues affecting clinical practice and patient safety.

MS Senate committee approves one medical marijuana bill, rejects another

Mississippi’s Senate committee debates which patient populations qualify for medical cannabis and where it can be administered clinically, directly affecting treatment options available to physicians.

Major Canadian Study Reveals Significant Connection Between Cannabis Use, – Bioengineer.org

This research documents bidirectional cannabis-mood disorder relationships, helping clinicians distinguish whether cannabis precedes psychiatric symptoms or follows them, critical for treatment planning.

DOSE) (OTCQB: RDTCF) Advances QuickStrip™ Research Backed by NFL … – StreetInsider

Sublingual/buccal thin-film delivery systems bypass hepatic metabolism, enabling faster onset and more consistent CBD absorption compared to oral formats—clinically relevant for dosing precision.

420 with CNW – Texas Grapples with Increasing Cases of Marijuana DUI

This article examines marijuana DUI cases in Texas and the lack of standardized THC blood thresholds for impairment detection—critical knowledge for clinicians assessing patient driving safety and legal liability.

Recreational Marijuana – Cons | Britannica

This article examines the pharmacological interaction between cannabis and alcohol, specifically how THC concentrations may affect alcohol consumption patterns, which is clinically relevant for managing co-use and substance dependence.

Feds warn about medical cannabis & hemp in drug tests (Newsletter: March 6, 2026)

Federal agencies warn that standard drug tests cannot reliably distinguish medical cannabis from legal hemp products, complicating patient monitoring and workplace compliance.

Recreational Marijuana – Cons | Britannica

This Britannica article presents documented disadvantages of recreational marijuana legalization, providing clinicians evidence-based information about potential harms relevant to patient counseling and clinical decision-making.

These Maine towns have the most cannabis businesses – The County

Maine towns’ cannabis business distribution data informs clinicians about local market density, regulatory environments, and patient access patterns that may affect clinical practice and patient sourcing.

DOH sets conditions on proposed medical cannabis legalization | Philippine News Agency

The Philippine DOH is establishing regulatory conditions for medical cannabis legalization, including patient access pathways and research frameworks—critical for clinicians seeking legal prescribing guidelines.

Building a global standard for cannabis vapes one terpene at a time – MJBizDaily

This article addresses standardization of terpene profiles in cannabis vape products, relevant to clinicians because terpenes may modulate cannabinoid effects and influence patient outcomes.

Cooney introduces bill to allow selling of low-potency cannabis beverages at liquor and wine stores

Low-dose THC beverages have distinct absorption kinetics compared to inhaled cannabis, requiring clinicians to understand dosing, onset timing, and individual metabolic variables for patient counseling.

How a virtual medical cannabis clinic is working on healthcare coverage for THC

This article examines how virtual medical cannabis clinics are addressing insurance coverage for THC products, highlighting cannabis’s potential role in reducing overall healthcare costs.

New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban Recovery

Poland’s medical cannabis market recovered after requiring in-person consultations instead of telemedicine, which clinicians should monitor for implications on patient access and prescription pathways.

DPH Commissioner goes ‘On the Record’ about measles outbreaks, cannabis – YouTube

Public health officials discuss rising THC potency in legal cannabis products and concerns about adolescent exposure, relevant to clinicians assessing patient risk factors and counseling youth.

The Coming Divide in Cannabis: Why the U.S. Market Remains Out of Reach for Global Operators

The U.S. federal prohibition of cannabis complicates drug development for clinicians by limiting access to cannabinoid medicines and research opportunities compared to other countries.

Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead

Brazil’s updated cannabis framework formally integrates medical cannabis into healthcare with domestic cultivation oversight and explicit THC product regulations, expanding clinical access and standardizing treatment protocols.

Branford industrial site sold, to become cannabis growing operation – The Wilton Bulletin

A Branford industrial property has been sold and will be converted into a cannabis cultivation facility, representing expansion of commercial cannabis growing operations in Connecticut.

Most cannabis users are ‘non-problematic’, Canadian data shows – leafie

Canadian data demonstrates most cannabis users don’t exhibit problematic patterns, challenging stigma and supporting clinicians’ need for individualized assessment rather than assumption-based treatment approaches.

US Cannabis Rescheduling: A Victory or a Federal Trap?

Federal cannabis rescheduling from Schedule I to III changes regulatory oversight but doesn’t resolve legal conflicts between state and federal law, directly affecting clinical practice and patient access.

Rapid Dose Therapeutics Advances Cannabinoid Studies for QuickStrip Drug Delivery Platform

Rapid Dose Therapeutics is developing oral thin film technology to deliver cannabinoids with improved dose consistency and faster onset compared to standard delivery methods.

Scientists Reveal What Types Of Food The Marijuana ‘Munchies’ Make You Crave The Most

Cannabis increases appetite and specifically shifts food preferences toward high-calorie, high-fat and high-sugar foods, which clinicians should consider when counseling patients about metabolic and nutritional effects.

Key Congressional Committee Set To Vote On Delaying Federal Hemp THC Ban Next Week

Congressional committee may delay federal restrictions on hemp-derived THC products, affecting clinician guidance on patient access, product safety standards, and regulatory oversight.

Wisconsin Democrats File Bill to Legalize Adult-Use, Medical Cannabis; Regulate Intoxicating Hemp

Wisconsin Democrats propose legislation to legalize adult-use cannabis, establish a regulated medical program, and control intoxicating hemp products—directly affecting clinical cannabis prescribing standards and patient access.

Rare Cannabinoid Company Expands Mood Collection with New THC-Free CBC Gummies …

This article covers CBC, a non-intoxicating cannabinoid with distinct endocannabinoid system mechanisms, relevant to clinicians seeking THC-free options with potentially unique therapeutic profiles.

Maryland Senate Delays Vote on Bill Allowing Firefighters to Use Medical Cannabis Off-Duty

Maryland legislation proposes protecting off-duty medical cannabis use by firefighters and first responders for occupational conditions like chronic pain, PTSD, and sleep disorders.

Upper Township unanimous for weed zone, overriding complaints from residents

Upper Township unanimously approved a cannabis retail zone despite resident opposition, which impacts clinicians’ ability to refer patients to regulated dispensaries in that jurisdiction.

Medical cannabis delivery app seeing growth in the DMV and Jamaica | DC News Now

This article covers growth in cannabis delivery apps in the DC/Maryland/Virginia region and Jamaica, relevant to clinicians as delivery services improve patient access for mobility-limited and chronically ill patients.

Cannabis industry launches organization to further US policy changes with members from …

**A cross-border cannabis industry coalition is organizing to influence US federal rescheduling policy, which directly impacts regulatory frameworks affecting patient access and producer operations.** (39 words)

The Best CBD for Seniors in 2026: Safe, Lab-Tested, and Easy to Use | stupidDOPE

This article reviews CBD products marketed to seniors for managing pain, sleep, and anxiety—relevant to clinicians assessing cannabinoid use in older adult populations.

Indiana lawmakers miss deadline, killing key cannabis bill | News | wthitv.com

Indiana failed to pass cannabis reform legislation, leaving the state with outdated policy while neighboring states expand patient access programs.

Hemp products had illegal THC amounts, mold, pesticides, and carcinogens, investigation finds

Unregulated hemp products frequently contain mislabeled THC levels and harmful contaminants, requiring clinicians to counsel patients on testing verification and potential safety risks.

Many NC candidates support medical marijuana legalization | Raleigh News & Observer

North Carolina candidates are expressing bipartisan support for medical marijuana legalization despite the state’s current prohibition, which affects patient access to cannabis-based treatment options.

Does Weed Make You Harder or Easier to Manipulate? – Herb

Cannabis impairs prefrontal cortex function dose-dependently, affecting judgment and decision-making—critical knowledge for clinicians assessing cognitive impacts and patient vulnerability during treatment.

Aelis Farma’s AEF0117 THC Interaction Trial Withdrawn: What Investors Should Know

A clinical trial for AEF0117, a selective CB1 receptor modulator targeting THC-related adverse effects and cannabis use disorder, was withdrawn—relevant to understanding emerging pharmacological treatment options.

Pres. Trump’s Marijuana Executive Mandate Accelerates MMJ International Holdings … – Newswire

This article discusses how federal policy changes regarding cannabis scheduling may create business opportunities for pharmaceutical-grade cannabis manufacturers operating internationally, which could affect treatment availability and product standards.

Veterans Groups Urge Congress To Expand Psychedelics And Marijuana Access To …

Veterans organizations are advocating for expanded VA access to cannabis and psychedelics to address veteran suicide rates, reflecting emerging clinical evidence supporting these treatments.

The Fire Station partners with Citizens for a Safe & Clean Lake Superior for cannabis vape …

The Fire Station collaborates with Citizens for a Safe & Clean Lake Superior regarding cannabis vape products, relevant to clinicians monitoring patient access, product safety, and community health implications.

Boulder and CBD: The Entourage Effect Explained | About Boulder County Colorado

This article explains how multiple cannabis plant compounds work together to produce therapeutic effects beyond what isolated cannabinoids can achieve—relevant for clinicians selecting treatment formulations.

Indiana S.B. 250 could close Lafayette hemp-beverage sales without a key amendment

Indiana S.B. 250 proposes restrictions on hemp-derived cannabinoid beverages, potentially eliminating legal access to products patients currently use for symptom management.

The Best CBD for Immune Support and Daily Resilience in 2026 | stupidDOPE | Est. 2008

This article reviews CBD’s mechanism of action on the endocannabinoid system for managing inflammation, stress, and sleep—relevant physiological targets for clinical cannabinoid applications.

Louisiana Lawmakers Advance Adult-Use Cannabis Pilot Bill – KQKI News

Louisiana is advancing a limited adult-use cannabis pilot program, providing clinicians data on legal market sales, consumption patterns, and public health outcomes in a traditionally restrictive state.

As Congress debates hemp-derived THC ban, Pa. lawmakers look for other options

Hemp-derived THC products operate in regulatory limbo post-2018 Farm Bill, prompting Pennsylvania to develop state-level frameworks—clinically relevant for understanding product legality and standardization affecting patient access.

West Virginia House approves bill allowing medical cannabis edibles | WV News

West Virginia approved medical cannabis edibles, expanding patient access options and offering respiratory-safe alternatives for qualifying patients requiring cannabis-based treatment.

The Wait is Over: Medical Cannabis set to roll out in April | WHNT.com

Alabama’s medical cannabis program launching in April enables clinicians to recommend cannabis for qualifying conditions like chronic pain and PTSD, expanding treatment options in a historically restrictive state.

Branford industrial site sold, to become cannabis growing operation – New Haven Register

An industrial site in Branford has been sold and will be converted into a cannabis growing operation, representing commercial cultivation expansion in Connecticut.

Utah Lawmakers Pass Bill To Support Clinical Trials On Psychedelics For Veterans’ Mental Health

Utah lawmakers approved clinical trials of psychedelics for veteran mental health treatment, expanding research opportunities beyond cannabis into complementary therapeutic modalities for PTSD and related conditions.

The Best CBD for Mental Clarity and Focus in 2026 | stupidDOPE | Est. 2008

This article examines CBD’s neurobiological mechanisms—including endocannabinoid and serotonin receptor interactions—relevant to mental clarity and focus outcomes clinicians may consider when recommending CBD products.

Study uncovers another reason not to skimp on sleep – ASU News

Sleep deprivation impairs prefrontal cortex function, increasing impulsive decision-making and substance use risk—critical for clinicians assessing cannabis use patterns and counseling patients on behavioral modification.

OCM issues precautionary recall for select cannabis products tested by Keystone Lab – CBS 6 Albany

OCM issued a precautionary recall for cannabis products tested by Keystone Lab due to concerns about laboratory testing accuracy, affecting product safety verification for clinical use.

High Tide joins U.S. National Compassionate Care Council | HITI Stock News

High Tide’s participation in the National Compassionate Care Council advances standardized, evidence-based medical cannabis access protocols, improving clinical consistency and patient care across fragmented regulatory environments.

Oklahoma Seeks to Backtrack on Medical Marijuana as Pitfalls Multiply

Oklahoma’s rapid medical cannabis expansion created regulatory gaps in dispensary oversight and product consistency, presenting clinical challenges around product quality assurance and patient safety monitoring.

SA risks missing R40bn hemp industry opportunity without coherent strategy – Business Day

South Africa’s hemp industry lacks coordinated national strategy, risking R40 billion in economic opportunity across CBD products and industrial applications relevant to medicinal cannabis practitioners.

Kearney man charged with selling THC cartridges to undercover officer near school – Nebraska TV

A Nebraska man faced charges for selling THC cartridges to undercover law enforcement near a school, illustrating enforcement of cannabis sales restrictions in jurisdictions where cannabis remains illegal.

The Office Is Issuing A Recall On Multiple Adult-Use Cannabis Products Tested By Keystone …

Regulated cannabis product recalls due to failed safety testing (contaminants, potency mislabeling) directly impact clinician prescribing decisions and patient safety outcomes.

Linnea Achieves CEP Certification for Cannabidiol Isolate – Morningstar

CEP certification confirms cannabidiol isolate meets pharmaceutical-grade standards for identity, purity, and manufacturing consistency, enabling clinicians to prescribe with assured product quality and safety.

Substance use on the rise among Gen Z in their early 20s – Medical Xpress

This article examines increasing substance use patterns in early Gen Z adults, providing clinicians data on demographic trends relevant to patient assessment and treatment planning.

Senate Bill would repeal 24% wholesale tax on marijuana – WTVB

A proposed Senate bill seeks to eliminate a 24% wholesale marijuana tax implemented January 2026, directly affecting cannabis product pricing and accessibility for clinical patients.

R40bn opportunity for hemp industrialisation in South Africa requires policy support – LSF study

South African hemp industrialization could generate R40bn if government implements supportive policy, directly affecting medical cannabis supply chains and clinical access to regulated products.

Bill to require stricter packaging requirements for marijuana edibles dies in Oregon legislature

Oregon’s failed edible packaging bill would have mandated individual wrapping and standardized dosing to prevent accidental ingestion, particularly in pediatric cases—critical patient safety considerations for clinical practice.

Germany’s Medical Cannabis Boom: Data-Driven Insights for Investors | INN

Germany’s medical cannabis market analysis provides real-world patient efficacy data and treatment trends, informing clinical practice evidence and market understanding.

New study reveals how many Americans use CBD — and why | GreenState

This article reports epidemiological data on CBD usage prevalence and patterns across American demographics, providing clinicians with population-level information on patient consumer trends and reported therapeutic applications.

New Report: Poland Medical Cannabis Market Data Shows Full Post-Ban Recovery

Poland’s medical cannabis market recovery post-ban demonstrates renewed patient access and regulatory acceptance, providing clinicians with insights into European medical cannabis availability and commercial expansion.

Wisconsin Democrats Introduce Cannabis Legalization Bill – Law360 Tax Authority

CBD oil restores quality of life for sisters, sharing concerns about new regulations with hemp …

Two sisters report quality-of-life improvements with full-spectrum CBD containing THCA, while expressing concerns about regulatory changes potentially restricting access to THCA-containing products.

ACLU previews cannabis & guns arguments for Supreme Court (Newsletter: February 26, 2026)

Federal cannabis prohibition may enable gun denial for state-legal cannabis users, creating legal complexities that clinicians should understand when counseling patients about cannabis use implications.

Texas Voters Disapprove Of How State Officials Are Handling Marijuana And THC Laws, Poll Shows

Texas voters disapprove of state marijuana and THC regulation management, signaling potential policy shifts that clinicians should monitor for changes affecting patient access and product legality.

Bridging the Gap: Medical Cannabis, Regulators, and the Reality of Clinical Accountability

This article examines gaps between clinical practice demands and regulatory oversight in medical cannabis, addressing the need for standardized outcome accountability in patient care.

March 5 webinar offers parents lessons on drug/alcohol trends – Rice County, MN

A webinar educates parents on current cannabis and substance use trends affecting youth, helping clinicians understand community knowledge gaps and prevention messaging opportunities.

Michigan’s Marijuana Tax Experiment Should Be An Urgent Warning To Other States (Op-Ed)

Michigan’s high cannabis taxes are shifting consumers to illicit markets, which matters clinically because unregulated products lack quality/safety testing that legal dispensaries provide.

Curaleaf Earnings: International Growth Offsets Domestic Decline from Continued Price Compression

Curaleaf’s earnings show domestic cannabis sales declining from market competition while international growth partially compensates, directly affecting product availability and pricing clinicians encounter.

Kentucky bill would expand cannabis drink sales beyond liquor stores – WKYT

Kentucky SB 223 proposes regulatory frameworks for cannabis-infused beverages, expanding retail availability beyond liquor stores, which matters to clinicians for understanding patient access and dosing consistency in their jurisdiction.

Advanced drug testing improves patient care at MUSC

Advanced drug testing at MUSC enables lower-cost, more accurate THC detection, helping clinicians better understand patient cannabis use for tailored treatment planning.

As lawmakers in Richmond continue debating a path forward for retail marijuana sales …

Virginia lawmakers debate retail marijuana regulations despite insufficient state-specific evidence on health and social impacts, creating uncertainty for clinical practice guidelines and patient care standards.

Europe’s Medical Cannabis Market Surges Toward $13 Billion: Last Week in Weed Feb. 23 …

Europe’s medical cannabis market growth to $13 billion reflects expanding regulatory frameworks and commercial availability, directly affecting clinicians’ access to pharmaceutical-grade products for patient treatment.

Facing Hemp Ban, PA Lawmakers Race to Regulate THC Drinks and Products

Pennsylvania is establishing regulations for THC-containing hemp products amid increased federal enforcement, directly affecting clinical practice regarding patient access to and counseling about these readily available intoxicating substances.

Ricketts addresses Congress leaving Nebraska off list protecting state medical cannabis laws

Senator Ricketts declined to support federal protections for state medical cannabis laws, creating potential legal uncertainty for Nebraska cannabis clinicians and patients relying on state-authorized programs.

The Wait is Over: Medical Cannabis set to roll out in April | WKRG.com

Alabama’s medical cannabis program launches in April with dispensaries opening, providing clinicians access to a regulated cannabis option for patient treatment within their state.

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …

The FDA is escalating enforcement against cannabis beverage companies making unsubstantiated health claims, creating regulatory uncertainty that affects clinical product recommendations and patient counseling.

Popular Diabetes Drugs May Help Combat Multiple Addictions, Major Study Shows

GLP-1 receptor agonists (diabetes medications) showed efficacy reducing addictive behaviors across multiple substances, offering clinicians potential pharmacological options for patients with concurrent cannabis and other substance use disorders.

Louisville dispensary helps patients apply for medical cannabis cards at reduced cost | Wdrb-video

A Louisville dispensary is reducing application fees for medical cannabis cards, improving patient access to legal treatment documentation and potentially expanding the patient population seeking clinical cannabis care.

Best THCa Flower Strains for Relaxation: 2026 – Weedmaps

This article reviews THCa flower strains marketed for relaxation, highlighting caryophyllene’s role as a terpene with potential endocannabinoid interactions relevant to clinical cannabinoid applications.

Former Leon County deputy’s son gets 7 year prison sentence in drug trafficking case

This article reports a drug trafficking conviction involving illicit THC concentrate production and distribution, relevant to understanding legal consequences and illicit market dynamics affecting regulated cannabis access.

Alabama’s Aden Holloway arrested after authorities allegedly found over a pound of …

Alabama football player Aden Holloway faced felony marijuana possession charges, highlighting legal risks athletes face despite evolving cannabis policy landscapes.

New Mexico Governor Quietly Approves Psychedelic Therapy Funds for Low-Income

This article covers New Mexico’s funding approval for psychedelic therapy services targeting low-income populations, relevant to clinicians treating underserved cannabis and psychedelic patients.

Sky News host James Macpherson looks at reports indicating medical cannabis does not …

More details revealed on arrest of Alabama basketball star Aden Holloway: See the warrant

This article covers a collegiate athlete’s marijuana possession arrest and evidence details, relevant to clinicians understanding legal risks their patients face and state-specific enforcement patterns.

Alabama guard Aden Holloway arrested on marijuana charge – The Crimson White

University athlete’s drug arrest highlights legal consequences of cannabis possession and tax stamp violations in states with strict enforcement policies.

Alabama’s Aden Holloway, the Tide’s No. 2 scorer, arrested on felony drug charge

The digest reflects an emerging clinical interest in cannabinoid compounds, particularly CBD and CBG, as potential therapeutic agents for metabolic and pain conditions, supported by preliminary research demonstrating benefits in liver disease and myofascial pain management. Regulatory developments across multiple jurisdictions reveal ongoing tension between standardization efforts, such as potency caps, and industry resistance, while product innovation in delivery systems and formulations continues to advance. These trends suggest the field is moving toward greater therapeutic specificity and evidence generation, though significant gaps remain regarding long-term safety, optimal dosing, and comparative effectiveness against established treatments.